Literature DB >> 14690593

Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor.

Junjie Hu1, Jun Liu, Rodolfo Ghirlando, Alan R Saltiel, Stevan R Hubbard.   

Abstract

The adaptor protein APS is a substrate of the insulin receptor and couples receptor activation with phosphorylation of Cbl to facilitate glucose uptake. The interaction with the activated insulin receptor is mediated by the Src homology 2 (SH2) domain of APS. Here, we present the crystal structure of the APS SH2 domain in complex with the phosphorylated tyrosine kinase domain of the insulin receptor. The structure reveals a novel dimeric configuration of the APS SH2 domain, wherein the C-terminal half of each protomer is structurally divergent from conventional, monomeric SH2 domains. The APS SH2 dimer engages two kinase molecules, with pTyr-1158 of the kinase activation loop bound in the canonical phosphotyrosine binding pocket of the SH2 domain and a second phosphotyrosine, pTyr-1162, coordinated by two lysine residues in beta strand D. This structure provides a molecular visualization of one of the initial downstream recruitment events following insulin activation of its dimeric receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690593     DOI: 10.1016/s1097-2765(03)00487-8

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  41 in total

1.  Mechanism of phosphorylation-induced activation of phospholipase C-gamma isozymes.

Authors:  Aurelie Gresset; Stephanie N Hicks; T Kendall Harden; John Sondek
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

2.  Structural basis for the interaction between the growth factor-binding protein GRB10 and the E3 ubiquitin ligase NEDD4.

Authors:  Qingqiu Huang; Doletha M E Szebenyi
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

3.  Kinase activation through dimerization by human SH2-B.

Authors:  Masahiro Nishi; Eric D Werner; Byung-Chul Oh; J Daniel Frantz; Sirano Dhe-Paganon; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

4.  Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14.

Authors:  Rafael S Depetris; Junjie Hu; Ilana Gimpelevich; Lowenna J Holt; Roger J Daly; Stevan R Hubbard
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

Review 5.  Receptor tyrosine kinases: mechanisms of activation and signaling.

Authors:  Stevan R Hubbard; W Todd Miller
Journal:  Curr Opin Cell Biol       Date:  2007-02-16       Impact factor: 8.382

6.  Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.

Authors:  Minghua Li; Zhiqin Li; David L Morris; Liangyou Rui
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

7.  Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.

Authors:  Sigal Gery; Qi Cao; Saskia Gueller; Hongtao Xing; Ayalew Tefferi; H Phillip Koeffler
Journal:  J Leukoc Biol       Date:  2009-03-17       Impact factor: 4.962

8.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 9.  The insulin receptor: both a prototypical and atypical receptor tyrosine kinase.

Authors:  Stevan R Hubbard
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

Review 10.  Metabolic functions of glucocorticoid receptor in skeletal muscle.

Authors:  Taiyi Kuo; Charles A Harris; Jen-Chywan Wang
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.